This company listing is no longer active
Odonate Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$95.03m |
Equity | US$71.37m |
Total liabilities | US$34.40m |
Total assets | US$105.77m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4OD's short term assets ($99.6M) exceed its short term liabilities ($30.3M).
Long Term Liabilities: 4OD's short term assets ($99.6M) exceed its long term liabilities ($4.1M).
Debt to Equity History and Analysis
Debt Level: 4OD is debt free.
Reducing Debt: 4OD has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4OD has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4OD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.